NRX Pharmaceuticals, Inc. Temporary Equity, Carrying Amount, Period Increase (Decrease)
NRX Pharmaceuticals, Inc. (NRXP) reported Temporary Equity, Carrying Amount, Period Increase (Decrease) of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-21.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease · last filed 2021-05-21
- NRX Pharmaceuticals, Inc. temporary equity, carrying amount, period increase (decrease) for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- NRX Pharmaceuticals, Inc. temporary equity, carrying amount, period increase (decrease) for the quarter ending 2020-03-31 was $1.50M.
- NRX Pharmaceuticals, Inc. temporary equity, carrying amount, period increase (decrease) for the quarter ending 2018-12-31 was $29.14K.
- NRX Pharmaceuticals, Inc. temporary equity, carrying amount, period increase (decrease) for the quarter ending 2018-09-30 was $28.08K.
- NRX Pharmaceuticals, Inc. temporary equity, carrying amount, period increase (decrease) for fiscal 2020 was $414.58K, a 39.78% decline from fiscal 2019.
- NRX Pharmaceuticals, Inc. temporary equity, carrying amount, period increase (decrease) for fiscal 2019 was $688.43K, a 941.56% increase from fiscal 2018.
- NRX Pharmaceuticals, Inc. temporary equity, carrying amount, period increase (decrease) for fiscal 2018 was $66.10K.
| Period end | Temporary Equity, Carrying Amount, Period Increase (Decrease) 3 month | Temporary Equity, Carrying Amount, Period Increase (Decrease) 6 month | Temporary Equity, Carrying Amount, Period Increase (Decrease) 9 month | Temporary Equity, Carrying Amount, Period Increase (Decrease) 12 month | Temporary Equity, Carrying Amount, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-21 | ||||
| 2020-12-31 | $414.58K 10-K/A · filed 2021-05-14 | $1.50M 10-K · filed 2021-04-01 | |||
| 2020-03-31 | $1.50M 10-Q · filed 2021-05-21 | ||||
| 2019-12-31 | $688.43K 10-K/A · filed 2021-05-14 | ||||
| 2018-12-31 | $29.14K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $57.23K derived: sum of 2 quarters · filed 2020-03-30 | $50.62K derived: sum of 3 quarters · filed 2020-03-30 | $66.10K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $28.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $21.48K derived: sum of 2 quarters · filed 2018-11-08 | $36.95K 10-Q · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$6.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $8.87K 10-Q · filed 2018-08-08 | -$94.87K derived: sum of 3 quarters · filed 2019-03-15 | ||
| 2018-03-31 | $15.48K 10-Q · filed 2018-05-15 | -$88.27K derived: sum of 2 quarters · filed 2019-03-15 | |||
| 2017-12-31 | -$103.74K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |